Femasys Inc. (FEMY)
USD 1.12
(-2.61%)
USD 1.12
(-2.61%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -15.01 Million USD | -20.91% |
| 2022 | -12.41 Million USD | 47.81% |
| 2021 | -23.79 Million USD | -1778.54% |
| 2020 | -1.26 Million USD | 73.08% |
| 2019 | -4.7 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -6.46 Million USD | 41.06% |
| 2024 Q1 | -10.96 Million USD | 26.97% |
| 2023 FY | -15.01 Million USD | -20.91% |
| 2023 Q2 | -10.49 Million USD | -6.49% |
| 2023 Q1 | -9.85 Million USD | 20.34% |
| 2023 Q4 | -15.01 Million USD | -157.55% |
| 2023 Q3 | -5.82 Million USD | 44.46% |
| 2022 Q4 | -12.37 Million USD | 18.72% |
| 2022 Q2 | -18.09 Million USD | 13.9% |
| 2022 Q1 | -21.01 Million USD | 11.67% |
| 2022 FY | -12.41 Million USD | 47.81% |
| 2022 Q3 | -15.22 Million USD | 15.87% |
| 2021 Q1 | -30.69 Thousand USD | 97.58% |
| 2021 FY | -23.79 Million USD | -1778.54% |
| 2021 Q4 | -23.79 Million USD | 8.65% |
| 2021 Q3 | -26.04 Million USD | 8.18% |
| 2021 Q2 | -28.36 Million USD | -92304.35% |
| 2020 Q1 | 7.41 Million USD | 0.0% |
| 2020 Q4 | -1.26 Million USD | 0.0% |
| 2020 FY | -1.26 Million USD | 73.08% |
| 2019 FY | -4.7 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | 681.759% |
| AngioDynamics, Inc. | -70.14 Million USD | 78.593% |
| AtriCure, Inc. | -9.81 Million USD | -52.967% |
| Avinger, Inc. | 10.12 Million USD | 248.371% |
| Azenta, Inc. | -618.47 Million USD | 97.572% |
| BioLife Solutions, Inc. | 7.25 Million USD | 307.02% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 100.613% |
| Daxor Corporation | 755.65 Thousand USD | 2087.033% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | -921.442% |
| GlucoTrack, Inc. | -4.29 Million USD | -249.516% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 139.011% |
| Hologic, Inc. | 374.4 Million USD | 104.01% |
| ICU Medical, Inc. | 1.45 Billion USD | 101.035% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 99.436% |
| KORU Medical Systems, Inc. | -7.03 Million USD | -113.371% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | -190.205% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -250.213% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -250.213% |
| Masimo Corporation | 804 Million USD | 101.868% |
| Microbot Medical Inc. | -2.28 Million USD | -556.833% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | -56.478% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 104.968% |
| Nephros, Inc. | -2.47 Million USD | -507.657% |
| NovoCure Limited | 355.42 Million USD | 104.225% |
| NEXGEL, Inc. | 98 Thousand USD | 15421.628% |
| NEXGEL, Inc. | 98 Thousand USD | 15421.628% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 125.426% |
| OraSure Technologies, Inc. | -276.9 Million USD | 94.577% |
| Pro-Dex, Inc. | 10.91 Million USD | 237.552% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 57.369% |
| Predictive Oncology Inc. | -5.87 Million USD | -155.715% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | 595.685% |
| QuidelOrtho Corporation | 2.49 Billion USD | 100.602% |
| Repligen Corporation | -39.51 Million USD | 62.005% |
| Sanara MedTech Inc. | 6.64 Million USD | 325.966% |
| STAAR Surgical Company | -147.2 Million USD | 89.8% |
| Sharps Technology, Inc. | -3.01 Million USD | -398.362% |
| Utah Medical Products, Inc. | -92.52 Million USD | 83.772% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 100.764% |
| Jin Medical International Ltd. | -2.81 Million USD | -433.114% |